These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35563115)

  • 41. Coagulation factor XIII variants with altered thrombin activation rates.
    Andersen MD; Kjalke M; Bang S; Lautrup-Larsen I; Becker P; Andersen AS; Olsen OH; Stennicke HR
    Biol Chem; 2009 Dec; 390(12):1279-83. PubMed ID: 19804366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel deep intronic mutation in the coagulation factor XIII a chain gene leading to unexpected RNA splicing in a patient with factor XIII deficiency.
    Deng J; Li D; Mei H; Tang L; Wang HF; Hu Y
    BMC Med Genet; 2020 Jan; 21(1):9. PubMed ID: 31914974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
    Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A
    Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxidation-induced modifications of the catalytic subunits of plasma fibrin-stabilizing factor at the different stages of its activation identified by mass spectrometry.
    Vasilyeva A; Yurina L; Indeykina M; Bychkova A; Bugrova A; Biryukova M; Kononikhin A; Nikolaev E; Rosenfeld M
    Biochim Biophys Acta Proteins Proteom; 2018 Aug; 1866(8):875-884. PubMed ID: 29738861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The activation peptide of coagulation factor XIII is vital for its expression and stability.
    Handrkova H; Schroeder V; Kohler HP
    J Thromb Haemost; 2015 Aug; 13(8):1449-58. PubMed ID: 26083359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras.
    Hettasch JM; Peoples KA; Greenberg CS
    J Biol Chem; 1997 Oct; 272(40):25149-56. PubMed ID: 9312126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factor XIII subunit A as an intracellular transglutaminase.
    Adány R; Bárdos H
    Cell Mol Life Sci; 2003 Jun; 60(6):1049-60. PubMed ID: 12861374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
    Katona É; Muszbek L; Devreese K; Kovács KB; Bereczky Z; Jonkers M; Shemirani AH; Mondelaers V; Ermens AA
    Haemophilia; 2014 Jan; 20(1):114-20. PubMed ID: 24118344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of factor XIII subunits.
    Katona E; Pénzes K; Csapó A; Fazakas F; Udvardy ML; Bagoly Z; Orosz ZZ; Muszbek L
    Blood; 2014 Mar; 123(11):1757-63. PubMed ID: 24408323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants.
    Jadhav MA; Lucas RC; Goldsberry WN; Maurer MC
    Biochim Biophys Acta; 2011 Dec; 1814(12):1955-63. PubMed ID: 21798378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Employing mutants to study thrombin residues responsible for factor XIII activation peptide recognition: a kinetic study.
    Isetti G; Maurer MC
    Biochemistry; 2007 Mar; 46(9):2444-52. PubMed ID: 17286389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
    Beckman JD; Holle LA; Wolberg AS
    J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.
    Standeven KF; Ariëns RA; Whitaker P; Ashcroft AE; Weisel JW; Grant PJ
    Diabetes; 2002 Jan; 51(1):189-97. PubMed ID: 11756340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients.
    Ambroziak M; Kuryłowicz A; Budaj A
    J Thromb Thrombolysis; 2019 Oct; 48(3):519-527. PubMed ID: 30972713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA.
    Mikkola H; Muszbek L; Laiho E; Syrjälä M; Hämäläinen E; Haramura G; Salmi T; Peltonen L; Palotie A
    Blood; 1997 Feb; 89(4):1279-87. PubMed ID: 9028951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen Activation.
    Li B; Billur R; Maurer MC; Kohler HP; Raddatz Müller P; Alberio L; Schroeder V
    Thromb Haemost; 2018 Dec; 118(12):2037-2045. PubMed ID: 30419598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis.
    Andersson C; Kvist PH; McElhinney K; Baylis R; Gram LK; Pelzer H; Lauritzen B; Holm TL; Hogan S; Wu D; Turpin B; Miller W; Palumbo JS
    PLoS One; 2015; 10(6):e0128113. PubMed ID: 26098308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.
    Poole LG; Pant A; Baker KS; Kopec AK; Cline-Fedewa HM; Iismaa SE; Flick MJ; Luyendyk JP
    J Thromb Haemost; 2019 Jan; 17(1):113-125. PubMed ID: 30415489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
    Mezei ZA; Katona É; Kállai J; Bereczky Z; Somodi L; Molnár É; Kovács B; Miklós T; Ajzner É; Muszbek L
    Thromb Res; 2017 Oct; 158():93-97. PubMed ID: 28865246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.
    Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S
    Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.